Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	727,019 L.L
A02BC02	RAZON 40	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, enteric coated	1,252,461 L.L
A02BC02	GASTROPAN	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	568,445 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	294,302 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	440,780 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	837,214 L.L
A02BC02	RAZON 20	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, enteric coated	747,176 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	4,146,714 L.L
A02BC02	PANTONIX-JULPHAR	G	Pantoprazole - 40mg	40mg	Injectable powder for solution	260,705 L.L
A02BC02	PANTOPRAZOL SALA	G	Pantoprazole (sodium) - 40mg	40mg	Injectable powder for solution	503,941 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	271,456 L.L
A02BC03	JOSWE LANZOTEC 30	G	Lansoprazole - 30mg	30mg	Capsule	514,692 L.L
A02BC03	LPZ-30	G	Lansoprazole - 30mg	30mg	Capsule, delayed release	360,150 L.L
A02BC03	PEPTAZOLE	G	Lansoprazole - 30mg	30mg	Capsule	252,642 L.L
A02BC03	JOSWE LANZOTEC 15	G	Lansoprazole - 15mg	15mg	Capsule	270,112 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 10mg	10mg	Tablet, film coated	212,327 L.L
A02BC04	PARIET	B	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	779,429 L.L
A02BC04	PRASOLAN	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	230,373 L.L
A02BC04	PULOROS 28	G	Rabeprazole sodium - 20mg	20mg	Tablet, gastroresistant	706,861 L.L
A02BC04	RABEC	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, film coated	212,327 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RABEZOL 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC04	RAMEP	G	Rabeprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	518,809 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	282,847 L.L
A02BC04	RAZOLE 20	G	Rabeprazole sodium - 20mg	20mg	Tablet, enteric coated	639,925 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 20mg	20mg	Tablet, gastroresistant	1,005,194 L.L
A02BC05	NEXIUM	B	Esomeprazole (magnesium trihydrate) - 20mg	20mg	Tablet, gastroresistant	1,005,194 L.L
A02BC05	ESO TAD	G	Esomeprazole - 20mg	20mg	Capsule, hard, gastro-resistant	299,677 L.L
A02BC05	ESOCAP-UBSA	G	Esomeprazole - 20mg	20mg	Capsule	511,940 L.L

...

187